We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology

QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.
News

Boehringer Selects NOVA-EM for Their Global Environmental Monitoring Program

Boehringer Ingelheim plans to implement and validate the NOVA-EM (Environmental Monitoring) solution at multiple sites worldwide.

News

Fast Simple Method to Make and Modify Pyrimidine Nucleoside Analogues

New simple method enables modification of pyrimidine nucleosides, including AZT (zidovudine).
News

Cardiac Stem Cells from Heart Disease Patients May Be Harmful

TAU researchers discover molecular pathway involved in toxic interaction between host cells and immune system.
News

Grape-based Compounds May Kill Colon Cancer Stem Cells

Compounds from grapes may kill colon cancer stem cells both in a petri dish and in mice, according to a team of researchers.
Copper Catalyst Converts Carbon Dioxide to Ethanol content piece image
News

Copper Catalyst Converts Carbon Dioxide to Ethanol

Stanford discovery could lead to sustainable source of the fuel additive ethanol
News

Wyss Institute’s Organ Chips Get Smart and Go Electric

Human Organs-on-Chips technology has been enhanced to non-invasively report cells’ health, electrical activities and differentiation status
News

A New Test to Detect Anti-phospholipid Antibody Syndrome

Researchers have succeeded in identifying the exact spot where anti-phospholipid antibodies attach themselves, enabling the development of a more accurate and standardized diagnostic test.
News

CCDC Selects Dotmatics to Support 2D Queries in its New Cambridge Structural Database Web Application

Agreement delivers seamless user experience across 2D and 3D structures.
News

New Three-in-One Blood Test for Prostate Cancer

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.
Advertisement